Literature DB >> 33916875

Novel Long Noncoding RNA miR205HG Functions as an Esophageal Tumor-Suppressive Hedgehog Inhibitor.

Jee Hoon Song1,2, Alan H Tieu1,3, Yulan Cheng1, Ke Ma1, Venkata S Akshintala1, Cem Simsek1, Vishnu Prasath1, Eun Ji Shin1, Saowanee Ngamruengphong1, Mouen A Khashab1, John M Abraham1, Stephen J Meltzer1.   

Abstract

Barrett's esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC). Recently, long noncoding RNAs (lncRNAs) have been identified as key regulators of biological pathways. However, involvement of lncRNAs in the development of BE and EAC has not been well-studied. The aims of the current study were: (1) to study involvement of the lncRNA, miR205HG, in the development of BE and EAC; (2) to clarify the role of miR205HG in in vitro and in vivo experiments; and (3) to investigate the mechanism of miR205HG involving the Hedgehog (Hh) signaling pathway. These experiments revealed that miR205HG was downregulated in EAC vs. normal esophageal epithelia (NE) as well as in EAC cell lines, and its forced overexpression inhibited EAC cell proliferation and cell cycle progression in vitro. Similarly, overexpression of miR205HG inhibited xenograft tumor growth in mice In vivo. Finally, we show that one mechanism of action of miR205HG involves the Hh signaling pathway: miR205HG and Hh expression levels were inversely correlated in both EAC (r = -0.73) and BE (r = -0.83) tissues, and in vitro studies revealed details of Hh signaling inhibition induced by miR205HG. In conclusion, these findings establish that lncRNA miR205HG functions as a tumor suppressor in the development of BE and EAC, at least in part through its effect on the Hh signaling pathway.

Entities:  

Keywords:  Barrett’s esophagus; esophageal adenocarcinoma (EAC); hedgehog inhibitor; long noncoding RNA (lncRNAs)

Year:  2021        PMID: 33916875     DOI: 10.3390/cancers13071707

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  6 in total

1.  Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction.

Authors:  Kentaro Sugano; Stuart Jon Spechler; Emad M El-Omar; Kenneth E L McColl; Kaiyo Takubo; Takuji Gotoda; Mitsuhiro Fujishiro; Katsunori Iijima; Haruhiro Inoue; Takashi Kawai; Yoshikazu Kinoshita; Hiroto Miwa; Ken-Ichi Mukaisho; Kazunari Murakami; Yasuyuki Seto; Hisao Tajiri; Shobna Bhatia; Myung-Gyu Choi; Rebecca C Fitzgerald; Kwong Ming Fock; Khean-Lee Goh; Khek Yu Ho; Varocha Mahachai; Maria O'Donovan; Robert Odze; Richard Peek; Massimo Rugge; Prateek Sharma; Jose D Sollano; Michael Vieth; Justin Wu; Ming-Shiang Wu; Duowu Zou; Michio Kaminishi; Peter Malfertheiner
Journal:  Gut       Date:  2022-06-20       Impact factor: 31.793

Review 2.  Noncoding RNAs related to the hedgehog pathway in cancer: clinical implications and future perspectives.

Authors:  Jia Song; Yuexin Ge; Xiaoyu Sun; Qiutong Guan; Shiqiang Gong; Minjie Wei; Jumin Niu; Lin Zhao
Journal:  Mol Cancer       Date:  2022-05-17       Impact factor: 41.444

3.  MIR205HG/LEADR Long Noncoding RNA Binds to Primed Proximal Regulatory Regions in Prostate Basal Cells Through a Triplex- and Alu-Mediated Mechanism.

Authors:  Eugenia Bezzecchi; Giulia Pagani; Barbara Forte; Stefano Percio; Nadia Zaffaroni; Diletta Dolfini; Paolo Gandellini
Journal:  Front Cell Dev Biol       Date:  2022-06-17

4.  LncRNA miR205HG hinders HNRNPA0 translation: anti-oncogenic effects in esophageal carcinoma.

Authors:  Xiaoying Dong; Xuyuan Chen; Di Lu; Dingwei Diao; Xiguang Liu; Shijie Mai; Siyang Feng; Gang Xiong
Journal:  Mol Oncol       Date:  2021-12-20       Impact factor: 7.449

Review 5.  Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.

Authors:  Houri Razavi; Ali Katanforosh
Journal:  BMC Genomics       Date:  2022-05-07       Impact factor: 4.547

Review 6.  Prognostic, Diagnostic and Predictive Biomarkers in the Barrett's Oesophagus-Adenocarcinoma Disease Sequence.

Authors:  Darragh O'Dowd; Jacintha O'Sullivan; Simone Marcone
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.